Helen Dale

Helen Dale

Auto-generated profile, based on publicly available information

Helen Dale

Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom (H.D.)

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2023 in BioTech
Verified
Journal Article
Open access
PDF file
MAMaria Grazia Aruta
Maria Grazia Aruta
ELElisa Lari
Elisa Lari
DSDaniele De Simone
Daniele De Simone
BSBianca Semplici
Bianca Semplici
CSClaudia Semplici
Claudia Semplici
OCon behalf of the Vacc-iNTS Consortium Collaborators
on behalf of the Vacc-iNTS Consortium Collaborators
Nontyphoidal Salmonella (NTS) is a leading cause of morbidity and mortality caused by enteric pathogens worldwide in both children and adults, and vaccines are not yet available. The measurement of antigen-specific antibodies in the sera of vaccinated or convalescent individuals is crucial to understand the incidence of disease and the immunogenicity of vaccine candidates. A solid and standardized assay used to determine the level of specific anti-antigens IgG is therefore of paramount importance. In this work, we presented the characterization of a customized enzyme-linked immunosorbent assay (ELISA) with continuous readouts and a standardized definition of EU/mL. We assessed various performance parameters: standard curve accuracy, dilutional linearity, intermediate precision, specificity, limits of blanks, and quantification. The simplicity of the assay, its high sensitivity and specificity coupled with its low cost and the use of basic consumables and instruments without the need of high automation makes it suitable for transfer and application to different laboratories, including resource-limiting settings where the disease is endemic. This ELISA is, therefore, fit for purpose to be used for quantification of antibodies against Salmonella Typhimurium and Salmonella Enteritidis O-antigens in human samples, both for vaccine clinical trials and large sero-epidemiological studies.

16 December 2022 in Methods and Protocols
Verified
Journal Article
Open access
PDF file
MAMaria Grazia Aruta
Maria Grazia Aruta
DSDaniele De Simone
Daniele De Simone
HDHelen Dale
Helen Dale
Esmelda Blessings ChirwaEsmelda Blessings Chirwa
Esmelda Blessings Chirwa
IKInnocent Kadwala
Innocent Kadwala
OCon behalf of the Vacc-iNTS Consortium Collaborators
on behalf of the Vacc-iNTS Consortium Collaborators
Salmonella Typhimurium and Salmonella Enteritidis are leading causative agents of invasive nontyphoidal Salmonella (iNTS) disease, which represents one of the major causes of death and morbidity in sub-Saharan Africa, still partially underestimated. Large sero-epidemiological studies are necessary to unravel the burden of disease and guide the introduction of vaccines that are not yet available. Even if no correlate of protection has been determined so far for iNTS, the evaluation of complement-mediated functionality of antibodies generated towards natural infection or elicited upon vaccination may represent a big step towards this achievement. Here we present the setup and the intra-laboratory characterization in terms of repeatability, intermediate precision, linearity, and specificity of a high-throughput luminescence-based serum bactericidal assay (L-SBA). This method could be useful to perform sero-epidemiological studies across iNTS endemic countries and for evaluation of antibodies raised against iNTS vaccine candidates in upcoming clinical trials.

6 November 2025 in medRxiv
Verified
Preprint
Open access
PDF file
KLKate Marie Lewis
Kate Marie Lewis
HDHelen Dale
Helen Dale
DLDan Lewer
Dan Lewer
JDJohnny Downs
Johnny Downs
RBRuth Blackburn
Ruth Blackburn
Introduction: Evidence on demographic and socioeconomic differences in adolescent mental health service use is vital for developing equitable health policy and service responses. We quantified inequalities in referrals to National Health Service (NHS)-funded mental health services and NHS-hospital use for mental health concerns by social strata for secondary school pupils in England. Methods: We used linked records from state-funded schools and national health services (ECHILD) in England to create a secondary school cohort of pupils (age 11 years/Year 7 at entry) from 2012/13 to 2021/22. We measured rates of service use by gender, racial-ethnic group, region of residence, free school meal eligibility, and area-level deprivation defined by the index of multiple deprivation. Service contacts were captured by records in the Mental Health Services Data Set and Hospital Episode Statistics. Pupils were followed up until the first chronological event of: service contact, age 21 years, death or end of study (31st August 2022). Results: Of 5,629,719 pupils, 980,648 (17.4%) were referred to NHS-funded mental health services; a rate of 45.2 per 1000 person-years (95% confidence interval 45.1-45.2). Within stratum, rates of referrals were higher in females (55.5, 55.4-55.7) than males (35.7, 35.6-35.8), highest in White Irish Traveller (70.8, 66.2-75.8) and lowest in Pakistani racial-ethnic groups (20.8, 20.5-21.1), highest in the North East (58.2, 57.7-58.7) and lowest in London (37.7, 37.5-37.9). Adolescents who were eligible for free school meals had particularly high referral rates (75.3, 75.0-75.6) and there was a gradient in rates by quintiles of area-level deprivation. There was consistency in the sociodemographic patterns across mental health-related referrals, emergency department attendances, and hospital admissions. Conclusions: We find marked variation in mental health service use across social strata, but with consistency across different service types, indicating significant inequalities in the underlying prevalence of mental ill-health and access to services. Key Messages: What is already known on this topic: summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done: Improving access to mental health services for young people is a priority for the English National Health Service, but there is limited population-level information about rates of contacts across multiple health care services and with comprehensive coverage of England. What this study adds: summarise what we now know as a result of this study that we did not know before: Almost one fifth of pupils were referred to mental health services, with stark variation by gender, racial-ethnic group, free school meal eligibility, neighbourhood deprivation and region of residence Relative patterns of contacts by social strata were similar across emergency department attendances and hospital admissions How this study might affect research, practice or policy: Summarise the implications of this study: Clear differences in services contacts across social strata indicate significant inequalities, likely reflecting differential barriers to access, the acceptability of NHS services to specific population strata, as well as differences in the underlying prevalence of mental ill-health We find no evidence of disproportionate use of a single service type, suggesting that policies addressing inequalities should span across all services and must seek to address social determinants of health, including differential barriers to service use.

21 August 2024 in Wellcome Open Research
Verified
Journal Article
Open access
HDHelen Dale
Helen Dale
Esmelda Blessings ChirwaEsmelda Blessings Chirwa
Esmelda Blessings Chirwa
PPPriyanka Patel
Priyanka Patel
GMGeorgina Makuta
Georgina Makuta
FMFelistas Mwakiseghile
Felistas Mwakiseghile
VIVacc- Ints
Vacc- Ints
Background Non-typhoidal Salmonella (NTS) are a major cause of bloodstream infections amongst children in sub-Saharan Africa. A clear understanding of the seroepidemiology and correlates of protection for invasive NTS (iNTS) in relation to key risk factors (malaria, anaemia, malnutrition) in children in Africa is needed to inform strategies for disease control including vaccine implementation. Methodology The SAiNTS study is a prospective community cohort study with paired serology samples from 2500 Malawian children 0–5 years at baseline and three months to measure age-stratified acquisition of lipopolysaccharide (LPS) O-antigen antibody (IgG) and serum bactericidal activity to the main serovars causing iNTS (Salmonella Typhimurium and S. Enteritidis). Children are selected from mapped and censused randomly selected households in Chikwawa, Malawi; an area with substantial malaria burden. The sampling framework is set within a malaria vaccination (RTS,S/ AS01) phase 4 cluster randomized trial, known as the Epidemiology Study of Malaria Transmission Intensity (EPI-MAL), allowing exploration of the impact of malaria vaccination on acquisition of immunity to NTS. Risk factor data for invasive disease will be collected using rapid diagnostic tests for malaria and anaemia, anthropometry for malnutrition, and a validated questionnaire for indicators of socioeconomic status, water and sanitation. All data will be recorded through electronic case report forms using the REDCap and the Open Data Kit (ODK) platforms. Stool sample analysis includes NTS culture and pan-Salmonella polymerase chain reaction to assess enteric exposure and biomarkers of environmental enteric dysfunction. Cases with iNTS disease will be followed up for comparison with community controls. Conclusions The final cohort of 2500 children will allow investigation into the impact of risk factors for iNTS on the acquisition of immunity in children 0–5 years in an endemic setting, including comparisons to partner seroepidemiology studies in three other sub-Saharan African sites (1000 children per site). The data generated will be key to informing iNTS disease control measures including targeted risk factor interventions and vaccine implementation through investigation of correlates of protection and identifying windows of immune susceptibility in at-risk populations.

1 September 2026 in Annals of Internal Medicine
Verified
Journal Article
Closed access
SMShruti Murthy
Shruti Murthy
CMChristian S. Marchello
Christian S. Marchello
NHNienke N. Hagedoorn
Nienke N. Hagedoorn
SFSuzanne Faigan
Suzanne Faigan
JAJason R. Andrews
Jason R. Andrews
JCJohn A. Crump
John A. Crump
Prevalence and incidence are fundamental metrics with numerous applications in epidemiology. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guideline lacks specific items for reporting studies of disease prevalence or incidence. To address this gap, the STROBE Enhanced Prevalence and Incidence Criteria (STROBE EPIC) extension was developed in accordance with established methods for reporting guideline development. The authors generated an initial list of reporting items, conducted a modified Delphi process, and convened a face-to-face consensus meeting to confirm the need for a STROBE extension and to generate an early version of the checklist. They conducted 2 further Delphi surveys, first extending from typhoid and other invasive salmonelloses to all infectious diseases, and then to noncommunicable diseases and injuries. Finally, experts piloted the checklist on relevant manuscripts to critically assess if it was clear, concise, complete, and free of errors. An executive group curated the checklist after every survey round. The STROBE EPIC checklist comprises 47 items in the domains of title (1 item), abstract (2 items), introduction (1 item), methods (25 items), results (6 items), discussion (7 items), and other information (5 items). STROBE EPIC items address reporting of study design, adjustment factors for underreporting and underdiagnosis, denominator population estimation, case ascertainment methods, factors producing artefactual changes to observed disease prevalence or incidence, limitations of incomplete surveillance coverage, generalizability of short-duration studies, and data availability. The authors anticipate that the STROBE EPIC extension will be used by researchers, authors, modelers, burden-of-disease researchers, peer reviewers, and journal editors to optimize the presentation of epidemiologic evidence to support diverse health policy decisions.

16 October 2025 in Wellcome Open Research
Verified
Journal Article
Open access
PJPeter I. Johnston
Peter I. Johnston
KCKenneth Chizani
Kenneth Chizani
ECEsmeda Chirwa
Esmeda Chirwa
HDHelen Dale
Helen Dale
PPPyianka Patel
Pyianka Patel
TNTonney Nyirenda
Tonney Nyirenda
Background Invasive non-typhoidal Salmonella (iNTS) disease is a leading cause of community-onset bloodstream infection in Africa, driving high morbidity in young children. The World Health Organization has published preferred product characteristics for an iNTS vaccine, but lack of transmission data is an impediment to vaccine licensure. Enteric NTS (eNTS) is the asymptomatic carriage of NTS in stool that precedes invasive disease. We do not know how long eNTS shedding lasts, how often infection spreads in endemic settings, or how an eNTS episode shapes immunity against later invasion. These gaps make it difficult to define trial sites, select cohorts, refine target product profiles, and build reliable models of vaccine impact. Here we describe TiNTS, a prospective household study in Blantyre, Malawi, which will measure real-time eNTS incidence, transmission, and antibody responses to close these evidence gaps and accelerate rational vaccine deployment. Methods We will recruit all members of at least 60 households in Ndirande, Blantyre, Malawi. Stool samples will be collected every other day for at least four weeks and tested for NTS using culture and pan- Salmonella PCR on growth media. Environmental samples collected at enrolment will be tested using the same methods. Symptoms and exposure risks will be recorded throughout. We will collect blood samples at enrolment, after four weeks, and four weeks after the first eNTS episode in each household. We will measure serum IgG responses to Salmonella Typhimurium and Enteritidis LPS antigens. We will extend follow-up if participants continue shedding or if the first household case occurs with fewer than 14 days of follow-up remaining. All culture-positive isolates and PCR-positive broths will undergo Illumina sequencing to enable genome and metagenome reconstruction for transmission inference. Conclusions TiNTS will define the burden, transmission patterns, and immune response to eNTS. Findings will inform vaccine modelling, trial design, and targeted introduction strategies.